Hospital Authority, Hong Kong
Hong Kong, 00000
Location status: Recruiting
NCT Number: NCT06776159
Improper subcutaneous administration of LMWH may cause complications at the injection site. Standardized protocol for subcutaneous LMWH injections in patient with cardiovascular diseases is warranted to ensure consistent best practices in clinical settings.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Hong Kong, 00000
Location status: Recruiting
This study examines the effect of standardized protocol in reducing complications for patients with cardiovascular disease.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients in the control group will receive the usual practice of subcutaneous LMWH injection administered by nurses.
Nurses administer LMWH according to the standardized evidence-based protocol.
Time frame: 24 hours, 48 hours, 72 hours
The bruising diameter will be measured by a ruler and the incidence of bruising will be recorded.
Time frame: Immediately after injection, 24 hours, 48 hours, 72 hours
Patients' pain levels are assessed using the Verbal Descriptor Scale: 'severe pain,' 'moderate pain,' 'mild pain,' and 'no pain.' 'Severe pain' indicates the worst outcome, followed by 'moderate pain,' then 'mild pain,' with 'no pain' representing the best outcome.
Time frame: Immediately after receiving the injection
a Patient Experience Surveys to evaluate their perceived nurse's attitude
Time frame: Immediately before and after injection
Communicative Competence Scale consists of 36 items across five dimensions (General Competence, Empathy Affiliation/Support, Behavioural Flexibility, and Social Relaxation), using a 5-point Likert scales ranging from strongly agree to strongly disagree (coded from 1 to 5). Higher the score means worse the outcome.
Contact information is provided by the study sponsor or research team.
Arkers Wong
CONTACT
Frankie CHEUNG
CONTACT
The Hong Kong Polytechnic University
Other
The Effect of Standardizing Procedures for Subcutaneous Injections of Low-molecular-weight Heparin on Patients With Cardiovascular Diseases: A Cluster Randomized Controlled Trial
Acronym: LMWH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06908590
CVD - Cardiovascular Disease, Cardiovascular Diseases
Baltimore, Maryland, United States
View Trial DetailsNCT07298213
CVD - Cardiovascular Disease, Cardiovascular Diseases
Tucson, Arizona, United States
View Trial DetailsNCT07061145
Bone Marrow Diseases, CVD - Cardiovascular Disease
Reggio Emilia, RE, Italy
View Trial DetailsNCT04258813
Adenocarcinoma, Adnexal Diseases
Durham, North Carolina, United States
View Trial Details